Mamdouh F A Mohamed (Mamdouh Fa Mohamed)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Structural Basis

Pulmonary Tuberculosis

Histone Deacetylase

Top Venues

Future medicinal chemistry

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry (2024)
Ahmad J Almalki, Tarek S Ibrahim, Ehab S Taher, Mamdouh F A Mohamed, Mahmoud Youns, Wael A H Hegazy, Amany M M Al-Mahmoudy
Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4 H )-Oxazolone-Based Sulfonamides. Molecules (Basel, Switzerland) 27 (3) (2022)
Eman A Ahmed, Mamdouh F A Mohamed, Omran A Omran
Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents. RSC advances 12 (39) (2022)
Tarek S Ibrahim, Azizah M Malebari, Mamdouh F A Mohamed
Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Tarek S Ibrahim, Amr Hassan Moustafa, Ahmad J Almalki, Rasha M Allam, Abdulhamid Althagafi, Shadab Md, Mamdouh F A Mohamed
Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Nourhan Hisham Shady, Alaa M Hayallah, Mamdouh F A Mohamed, Mohammed M Ghoneim, Garri Chilingaryan, Mohammad M Al-Sanea, Mostafa A Fouad, Mohamed Salah Kamel, Usama Ramadan Abdelmohsen
Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study. Molecules (Basel, Switzerland) 26 (12) (2021)
Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Tarek S Ibrahim, Mai E Shoman, Ebtihal Samir, Rehab M Abd El-Baky
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. RSC advances 10 (45) (2020)
Heba Ali Hassan, Ahmed E Allam, Dalia H Abu-Baih, Mamdouh F A Mohamed, Usama Ramadan Abdelmohsen, Kuniyoshi Shimizu, Samar Y Desoukey, Alaa M Hayallah, Mahmoud A Elrehany, Khaled M Mohamed, Mohamed S Kamel
Isolation and characterization of novel acetylcholinesterase inhibitors from Ficus benghalensis L. leaves. RSC advances 10 (60) (2020)
Tarek S Ibrahim, Ehab S Taher, Ebtihal Samir, Azizah M Malebari, Ahdab N Khayyat, Mamdouh F A Mohamed, Riham M Bokhtia, Mohammed A AlAwadh, Israa A Seliem, Hani Z Asfour, Nabil Abdulhafiz Alhakamy, Siva S Panda, Amany M M Al-Mahmoudy
In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors. Molecules (Basel, Switzerland) 25 (14) (2020)
Mamdouh F A Mohamed, Gamal El-Din A Abuo-Rahma
Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review. RSC advances 10 (52) (2020)